Bischof, T.; Schaller, C.; Buchtele, N.; Staudinger, T.; Ullrich, R.; Kraft, F.; Andersson, M.L.; Jilma, B.; Schoergenhofer, C.
Drug–Drug Interactions in Patients with Acute Respiratory Distress Syndrome. Pharmaceutics 2024, 16, 303.
https://doi.org/10.3390/pharmaceutics16030303
AMA Style
Bischof T, Schaller C, Buchtele N, Staudinger T, Ullrich R, Kraft F, Andersson ML, Jilma B, Schoergenhofer C.
Drug–Drug Interactions in Patients with Acute Respiratory Distress Syndrome. Pharmaceutics. 2024; 16(3):303.
https://doi.org/10.3390/pharmaceutics16030303
Chicago/Turabian Style
Bischof, Thorsten, Christoph Schaller, Nina Buchtele, Thomas Staudinger, Roman Ullrich, Felix Kraft, Marine L. Andersson, Bernd Jilma, and Christian Schoergenhofer.
2024. "Drug–Drug Interactions in Patients with Acute Respiratory Distress Syndrome" Pharmaceutics 16, no. 3: 303.
https://doi.org/10.3390/pharmaceutics16030303
APA Style
Bischof, T., Schaller, C., Buchtele, N., Staudinger, T., Ullrich, R., Kraft, F., Andersson, M. L., Jilma, B., & Schoergenhofer, C.
(2024). Drug–Drug Interactions in Patients with Acute Respiratory Distress Syndrome. Pharmaceutics, 16(3), 303.
https://doi.org/10.3390/pharmaceutics16030303